Daniel R. Ganger

Fast Facts and Concepts #536: Hepatorenal Syndrome-Acute Kidney Injury in End-Stage Liver Disease.

Journal: Journal of palliative medicine

Published: July 03, 2026

Integrating Palliative Care in End-Stage Liver Disease: An Interprofessional Perspective on Communication, Terminology, and Educational Gaps.

Journal: Journal of palliative medicine

Published: April 27, 2026

Erratum: Clinically relevant cut-points for changes in the Liver Frailty Index are associated with waitlist mortality in patients with cirrhosis.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: April 20, 2026

The Liver Frailty Index improves mortality risk prediction for GEMA-Na.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: March 03, 2026

Frailty 1 year after liver transplant is associated with long-term mortality: From the Functional Assessment in Liver Transplantation (FrAILT) Study.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: February 26, 2026

Safety and Feasibility of Yttrium-90 Radioembolization for Cirrhosis-Induced Splenomegaly and Thrombocytopenia: Results from an Investigational Device Exemption Study.

Journal: Journal of vascular and interventional radiology : JVIR

Published: December 11, 2025

Hepatic cholate clearance as assessed by HepQuant-SHUNT is associated with clinical outcomes in individuals with Fontan circulation.

Journal: International journal of cardiology. Congenital heart disease

Published: December 11, 2025

The Liver Transplant Comorbidity Index (LTCI): A composite index of ambulatory pre-LT factors to identify patients at increased risk of post-LT mortality.

Journal: Hepatology (Baltimore, Md.)

Published: January 08, 2025

Clinical and pathological spectrum of disease severity among patients with acute liver failure (ALF) undergoing deceased donor liver transplantation.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: November 30, 2024

Fast Facts and Concepts #536: Hepatorenal Syndrome-Acute Kidney Injury in End-Stage Liver Disease.

Fast Facts and Concepts #536: Hepatorenal Syndrome-Acute Kidney Injury in End-Stage Liver Disease.

Integrating Palliative Care in End-Stage Liver Disease: An Interprofessional Perspective on Communication, Terminology, and Educational Gaps.

Integrating Palliative Care in End-Stage Liver Disease: An Interprofessional Perspective on Communication, Terminology, and Educational Gaps.

Erratum: Clinically relevant cut-points for changes in the Liver Frailty Index are associated with waitlist mortality in patients with cirrhosis.

Erratum: Clinically relevant cut-points for changes in the Liver Frailty Index are associated with waitlist mortality in patients with cirrhosis.

The Liver Frailty Index improves mortality risk prediction for GEMA-Na.

The Liver Frailty Index improves mortality risk prediction for GEMA-Na.

Frailty 1 year after liver transplant is associated with long-term mortality: From the Functional Assessment in Liver Transplantation (FrAILT) Study.

Frailty 1 year after liver transplant is associated with long-term mortality: From the Functional Assessment in Liver Transplantation (FrAILT) Study.

Safety and Feasibility of Yttrium-90 Radioembolization for Cirrhosis-Induced Splenomegaly and Thrombocytopenia: Results from an Investigational Device Exemption Study.

Safety and Feasibility of Yttrium-90 Radioembolization for Cirrhosis-Induced Splenomegaly and Thrombocytopenia: Results from an Investigational Device Exemption Study.

Hepatic cholate clearance as assessed by HepQuant-SHUNT is associated with clinical outcomes in individuals with Fontan circulation.

Hepatic cholate clearance as assessed by HepQuant-SHUNT is associated with clinical outcomes in individuals with Fontan circulation.

Treatment of hepatocellular carcinoma in patients with Fontan-associated liver disease with radioembolisation therapy.

Treatment of hepatocellular carcinoma in patients with Fontan-associated liver disease with radioembolisation therapy.

Treatment of hepatocellular carcinoma in patients with Fontan-associated liver disease with radioembolisation therapy.

Treatment of hepatocellular carcinoma in patients with Fontan-associated liver disease with radioembolisation therapy.

Larsucosterol for the Treatment of Alcohol-Associated Hepatitis.

Larsucosterol for the Treatment of Alcohol-Associated Hepatitis.

The Liver Transplant Comorbidity Index (LTCI): A composite index of ambulatory pre-LT factors to identify patients at increased risk of post-LT mortality.

The Liver Transplant Comorbidity Index (LTCI): A composite index of ambulatory pre-LT factors to identify patients at increased risk of post-LT mortality.

Clinical and pathological spectrum of disease severity among patients with acute liver failure (ALF) undergoing deceased donor liver transplantation.

Clinical and pathological spectrum of disease severity among patients with acute liver failure (ALF) undergoing deceased donor liver transplantation.